Omega Healthcare Investors (OHI) to Release Earnings on Wednesday

Omega Healthcare Investors (NYSE:OHI) is expected to be releasing its Q4 2025 results after the market closes on Wednesday, February 4th. Analysts expect Omega Healthcare Investors to post earnings of $0.79 per share and revenue of $287.1840 million for the quarter. Omega Healthcare Investors has set its FY 2025 guidance at 3.080-3.100 EPS. Investors are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Thursday, February 5, 2026 at 10:00 AM ET.

Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings data on Thursday, October 30th. The real estate investment trust reported $0.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.77 by $0.02. Omega Healthcare Investors had a return on equity of 10.72% and a net margin of 46.83%.The business had revenue of $311.59 million for the quarter, compared to analysts’ expectations of $262.48 million. During the same period in the previous year, the business posted $0.71 earnings per share. Omega Healthcare Investors’s quarterly revenue was up 14.4% on a year-over-year basis. On average, analysts expect Omega Healthcare Investors to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Omega Healthcare Investors Trading Down 1.8%

OHI stock opened at $43.22 on Wednesday. Omega Healthcare Investors has a 1-year low of $35.04 and a 1-year high of $46.36. The company has a current ratio of 7.11, a quick ratio of 7.11 and a debt-to-equity ratio of 0.95. The business’s 50 day moving average is $44.66 and its 200-day moving average is $42.39. The firm has a market cap of $12.77 billion, a P/E ratio of 24.15, a P/E/G ratio of 1.42 and a beta of 0.57.

Wall Street Analyst Weigh In

OHI has been the topic of several recent analyst reports. Truist Financial lifted their price objective on shares of Omega Healthcare Investors from $44.00 to $46.00 and gave the stock a “hold” rating in a research note on Monday, December 1st. Citigroup reissued a “buy” rating and set a $50.00 price target (up from $45.00) on shares of Omega Healthcare Investors in a research report on Wednesday, November 12th. Royal Bank Of Canada upped their price objective on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the company a “sector perform” rating in a research report on Thursday, November 6th. Weiss Ratings lowered Omega Healthcare Investors from a “buy (a-)” rating to a “buy (b+)” rating in a report on Monday, January 12th. Finally, Jefferies Financial Group reissued a “hold” rating and issued a $45.00 target price on shares of Omega Healthcare Investors in a research note on Monday, December 15th. Seven research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $47.09.

Insider Buying and Selling

In related news, CEO C Taylor Pickett purchased 20,000 shares of Omega Healthcare Investors stock in a transaction on Wednesday, November 5th. The stock was acquired at an average cost of $43.14 per share, for a total transaction of $862,800.00. Following the completion of the acquisition, the chief executive officer owned 20,000 shares of the company’s stock, valued at $862,800. This trade represents a ∞ increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CIO Vikas Gupta acquired 11,500 shares of the stock in a transaction dated Thursday, November 6th. The stock was bought at an average cost of $42.97 per share, with a total value of $494,155.00. Following the completion of the purchase, the executive owned 13,773 shares of the company’s stock, valued at approximately $591,825.81. The trade was a 505.94% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 1.50% of the company’s stock.

Hedge Funds Weigh In On Omega Healthcare Investors

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Sivia Capital Partners LLC purchased a new stake in Omega Healthcare Investors during the second quarter valued at approximately $257,000. Rehmann Capital Advisory Group bought a new stake in shares of Omega Healthcare Investors during the 3rd quarter valued at $361,000. Mackenzie Financial Corp purchased a new stake in shares of Omega Healthcare Investors in the 3rd quarter worth $415,000. Jefferies Financial Group Inc. bought a new position in Omega Healthcare Investors in the 3rd quarter worth $298,000. Finally, B. Riley Wealth Advisors Inc. purchased a new position in Omega Healthcare Investors during the second quarter valued at $343,000. 65.25% of the stock is currently owned by hedge funds and other institutional investors.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.